Bone metastasis after a resection of stage I and II primary lung cancer

Lung Cancer

Volumn 27, Issue 3, 2000, Pages 199-204

  Hanagiri, Takeshi ^a   Kodate, Mantaro ^b   Nagashima, Akira ^b   Sugaya, Masakazu ^b   Dobashi, Kazuhito ^b   Ono, Minoru ^b   Yasumoto, Kosei ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KITAKYUSHU MUNICIPAL MEDICAL CENTER   (Japan)

Author keywords

Bone metastasis; Bone scintigraphy; Lung cancer; Lymphatic vessel invasion

Indexed keywords

ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH VESSEL; MAJOR CLINICAL STUDY; MICROSCOPY; PATHOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

ADENOCARCINOMA; BONE NEOPLASMS; CARCINOMA, SQUAMOUS CELL; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; SURVIVAL ANALYSIS;

EID: 0034159975     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(99)00108-7     Document Type: Article

References (22)

1. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer Statistics, 1998. CA Cancer J. Clin. 48:1998;6-29.
2. Damstrup L., Poulson H.S. Review of the curative role of radiotherapy in the treatment of non-small cell lung cancer. Lung Cancer. 11:1994;153-178.
3. Grili R., Oxman A.D., Julian J.A. Chemotherapy for advanced non small-cell lung cancer: How much benefit is enough. J. Clin. Oncol. 11:1993;1855-1872.
4. Mountain C.F. Revisions in the international system for staging lung cancer. Chest. 111:1997;1710-1717.
5. Strauss B., Carl V. Bronchogenic carcinoma. A statistical analysis of 296 cases with necropsy as to relationships between cell types and age, sex, and metastases. Arch. Pathol. 63:1957;602-611.
6. Spjut H.J., Mateo J.E. Recurrent and metastatic carcinoma in surgically treated carcinoma of lung. Cancer. 18:1965;1462-1466.
7. Feld R., Rubenstein L.V., Weisenberger T.H. Sites of recurrence in resected stage I-non-small cell lung cancer: a guide for future studies. J. Clin. Oncol. 2:1984;1352-1358.
8. Greenberg E.J., Weber D.A., Pochaczevsky R. Detection of neoplastic bone lesions by quantitative scanning and radiography. J. Nucl. Med. 9:1968;613-620.
9. Donato A.T., Ammerman L.G., Sullesta O. Bone scanning in the evaluation of patients with lung cancer. Ann. Thorac. Surg. 27:1979;300-304.
10. Perez D.J., Powels T.J., Milan J., Gazet J.C., Ford H.T., McCready V.R. et al. Detection of breast carcinoma metastases in bone: relative merit of X-rays and skeletal scintigraphy. Lancet. 2:1983;613-616.
11. World Health Organization. Histological Typing of Lung Tumours. 2nd ed. Geneva: International Histological Classification of Tumours, 1981.
12. Read R.C., Yoder G., Schaeffer R.C. Survival after conservative resection for TlN0M0 non-small cell lung cancer. Ann. Thorac. Surg. 49:1990;391-400.
13. Thomas P, Rubinstein L, Lung Cancer Study Group. Cancer recurrence after resection: T1N0 non-small cell lung cancer, Ann. Thorac. Surg. 1990;49:242-247.
14. Smith PH, Bono A, Silva C, Debroyne F, Denis L, Robinson P, Sylvester R, Armitage TG, the EORTC Urological group. Some limitations of the radioisotope bone scan in patients with metastatic prostatic cancer. A subanalysis of EORTC trial 30853, Cancer 1990;66:1009-1016.
15. O'Mara R.E., Weber D.A. The osseous system. Freeman L.M. Freeman and Johnson's Clinical Radionuclide Imaging. 1984;1141-1179 Grune and Stratton, New York.
16. Mountain C.F., Lukeman J.M., Hammer S.P. Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population. J. Surg. Oncol. 35:1987;147-156.
17. Hansen H.H., Franco M.M. Staging of inoperable patients with bronchogenic carcinoma with special reference to bone mallow examination and peritoneoscopy. Cancer. 30:1972;1395-1410.
18. Macchiarini P., Fontanini G., Hardin J. Most peripheral, node negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion. J. Thorac. Cardiovasc. Surg. 104:1992;892-899.
19. Blomqvist C., Risteli L., Virkkunen P., Sarna S., Eilomaa I. Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma. Br. J. Cancer. 73:1996;1074-1079.
20. Aruga A., Koizumi M., Hotta R., Takahashi S., Ogata E. Usefulness of bone metabolic markers in the diagnosis and follow-up of bone metastasis from lung cancer. Br. J. Cancer. 76:1997;760-764.
21. Pantel K., Izbicki J., Passlick B., Angstwurm M., Haussinger K., Thetter O. et al. Frequency and prognostic significance of isolated tumor cells in bone mallow of patients with non-small-cell lung cancer without overt metastasis. Lancet. 347:1996;649-653.
22. Ohgami A., Mitsudomi T., Sugio K., Tsuda T., Oyama T., Nishida K. et al. Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer. Ann. Thorac. Surg. 64:1997;363-367.